1. Home
  2. TVTX vs RES Comparison

TVTX vs RES Comparison

Compare TVTX & RES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • RES
  • Stock Information
  • Founded
  • TVTX 2008
  • RES 1984
  • Country
  • TVTX United States
  • RES United States
  • Employees
  • TVTX N/A
  • RES N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • RES Oilfield Services/Equipment
  • Sector
  • TVTX Health Care
  • RES Energy
  • Exchange
  • TVTX Nasdaq
  • RES Nasdaq
  • Market Cap
  • TVTX 1.4B
  • RES 1.1B
  • IPO Year
  • TVTX N/A
  • RES N/A
  • Fundamental
  • Price
  • TVTX $16.48
  • RES $5.16
  • Analyst Decision
  • TVTX Strong Buy
  • RES Hold
  • Analyst Count
  • TVTX 16
  • RES 3
  • Target Price
  • TVTX $33.33
  • RES $5.75
  • AVG Volume (30 Days)
  • TVTX 1.5M
  • RES 1.8M
  • Earning Date
  • TVTX 07-31-2025
  • RES 07-24-2025
  • Dividend Yield
  • TVTX N/A
  • RES 3.11%
  • EPS Growth
  • TVTX N/A
  • RES N/A
  • EPS
  • TVTX N/A
  • RES 0.35
  • Revenue
  • TVTX $273,533,000.00
  • RES $1,370,043,000.00
  • Revenue This Year
  • TVTX $73.84
  • RES $16.54
  • Revenue Next Year
  • TVTX $46.72
  • RES $11.28
  • P/E Ratio
  • TVTX N/A
  • RES $14.58
  • Revenue Growth
  • TVTX 75.65
  • RES N/A
  • 52 Week Low
  • TVTX $7.93
  • RES $4.10
  • 52 Week High
  • TVTX $25.29
  • RES $7.54
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 59.73
  • RES 56.63
  • Support Level
  • TVTX $14.44
  • RES $5.05
  • Resistance Level
  • TVTX $16.64
  • RES $5.47
  • Average True Range (ATR)
  • TVTX 0.61
  • RES 0.22
  • MACD
  • TVTX 0.31
  • RES 0.03
  • Stochastic Oscillator
  • TVTX 94.18
  • RES 65.00

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.

Share on Social Networks: